Complement component 3 prevents imiquimod-induced psoriatic skin inflammation by inhibiting apoptosis in mice
- 1 August 2020
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 85, 106692
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81873881, 81900628)
- Natural Science Foundation of Chongqing Municipality
This publication has 44 references indexed in Scilit:
- A New Role of the Complement System: C3 Provides Protection in a Mouse Model of Lung Infection with Intracellular Chlamydia psittaciPLOS ONE, 2012
- Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in miceJournal of Clinical Investigation, 2012
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- IgG Autoantibodies against Deposited C3 Inhibit Macrophage-Mediated Apoptotic Cell Engulfment in Systemic AutoimmunityThe Journal of Immunology, 2011
- A Protective Role for Complement C3 Protein during Pandemic 2009 H1N1 and H5N1 Influenza A Virus InfectionPLOS ONE, 2011
- Psoriasis: what we have learned from mouse modelsNature Reviews Rheumatology, 2010
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- C1q Differentially Modulates Phagocytosis and Cytokine Responses during Ingestion of Apoptotic Cells by Human Monocytes, Macrophages, and Dendritic CellsThe Journal of Immunology, 2009
- C3 Promotes Expansion of CD8+ and CD4+ T Cells in a Listeria monocytogenes InfectionThe Journal of Immunology, 2009
- Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cellsClinical and Experimental Immunology, 2009